Assignee
OBEID MICHEL SARKIS
0 granted patents·11 pending applications·0 citations·filing 2007–2010
Top patents by PatentIndex Score
11 records- 0130US2009004134A1Kit for treating a health condition by inducing translocation of an erp57 protein to a cellular membraneOBEID MICHEL SARKIS·Filed 2007·Application pending·0 cites
- 0230US2009004172A1Service for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using erp57 translocationOBEID MICHEL SARKIS·Filed 2007·Application pending·0 cites
- 0330US2009048159A1Kit for treating a health condition by inducing translocation of a calreticulin protein to a cellular membraneOBEID MICHEL SARKIS·Filed 2007·Application pending·0 cites
- 0430US2008214452A1Method for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt translocationOBEID MICHEL SARKIS·Filed 2007·Application pending·0 cites
- 0520US2009010952A1Pharmaceutical compound for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt or erp57 translocationOBEID MICHEL SARKIS·Filed 2007·Application pending·0 cites
- 0620US2009004678A1Method for screening fertility and new compounds or molecules, using crt or erp57 translocationOBEID MICHEL SARKIS·Filed 2007·Application pending·0 cites
- 0720US2009004211A1Method for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using erp57 translocationOBEID MICHEL SARKIS·Filed 2007·Application pending·0 cites
- 0820US2009005305A1Service for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt translocationOBEID MICHEL SARKIS·Filed 2007·Application pending·0 cites
- 0919US2009004178A1Pharmaceutical compound for blocking the crt or erp57 translocationOBEID MICHEL SARKIS·Filed 2007·Application pending·0 cites
- 1019US2009005302A1Method, apparatus, and compound for effecting localized, non-systemic, immunogenic treatment of cancerOBEID MICHEL SARKIS·Filed 2007·Application pending·0 cites
- 1113US2011060120A1Immunogenic treatment of cancer by peptides inducing the plasma membrane exposure of erp57OBEID MICHEL SARKIS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when OBEID MICHEL SARKIS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →